Hints and tips:
Related Special Reports
...The company’s work to date has involved analysing thousands of donated human livers to develop an understanding of the causes of disease, and studying whether making changes to RNA — a vital molecule for...
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Scientists have invented a potential drug candidate that successfully combats antibiotic-resistant “superbugs” in non-human tests, according to research....
...insurers to cover the drug....
...Drugs companies issued 1,643 warnings of impending shortages in 2023, compared to 648 in 2020, the research found....
...The ruling came after Escobar Inc, the company set up by his brother, filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) for registration of the word sign Pablo Escobar...
...Esteban Santantino, director of analysis in the provincial security ministry, said it was impossible to give a number of the groups or individuals involved because they do not operate within the hierarchical...
...The company’s immunotherapy drug Imfinzi helped patients with so-called limited stage small cell lung cancer survive for longer....
...Emblaveo, marketed in Europe by US pharmaceutical company Pfizer, combines two existing medicines to tackle so-called Gram-negative bacteria that are among the leading drug-resistance threats....
...A top EU court has ruled that the name of the dead Colombian drug kingpin Pablo Escobar cannot be registered as a trademark in the EU....
...Finding an effective treatment for Alzheimer’s has proved fiendishly difficult for drug companies, and previous regulatory decisions in the field have stirred controversy....
...What processes are involved in plasticity? What is meant by ‘placebo’? Why is this a necessary part of drug research Outline examples of ‘brain scanning’ methods....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...other drug development....
...Roche recently agreed to buy the company for up to $3bn. The plan is to combine its drugs with ones in the Swiss company’s pipeline, with a view to preserving muscle mass....
...The company has genetically validated two other drug targets....
...Zosurabalpin’s emergence “opens the door” to tackling the broader Gram-negative pathogen group, according to Morgan Gugger and Prof Paul Hergenrother of Illinois university, who were not involved in the...
...Like their American counterparts, British rappers are frequently eager to chase credibility by claiming to be heavily involved in day-to-day lives of drug hustling, gun crime and casual violence....
...The debate over the role of obesity drugs has not yet been settled. In February’s mid-stage trials, Eli Lilly’s weight loss drug tirzepatide showed promise against MASH....
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...Patients with terminal breast cancer in England will miss out on a new drug already approved in Scotland, after spending watchdog NICE said Enhertu, developed by Japanese pharma company Daiichi Sankyo and...
...“NHS England expected drug companies AstraZeneca and Daiichi Sankyo to offer this treatment at a price that would enable Nice to recommend its use,” NHS England said....
...Instead, drugs companies will be on the hook for an uncapped 20 per cent share of catastrophic costs....
...Chief executive Lars Fruergaard Jørgensen told the Financial Times this month that it was assessing deals for biotech companies with mid-stage drugs....
International Edition